19,948 Procter & Gamble Company (The) $PG Shares Sold by Glenview Trust Co

Glenview Trust Co decreased its position in Procter & Gamble Company (The) (NYSE:PG) by 5.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 342,398 shares of the company’s stock after selling 19,948 shares during the period. Glenview Trust Co’s holdings in Procter & Gamble were worth $49,744,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PG. BlackRock Inc. acquired a new position in shares of Procter & Gamble in the second quarter valued at about $27,862,105,000. State Street Corp raised its stake in shares of Procter & Gamble by 1.0% in the second quarter. State Street Corp now owns 102,216,308 shares of the company’s stock worth $14,988,999,000 after purchasing an additional 965,461 shares during the last quarter. Bank of America Corp DE purchased a new position in shares of Procter & Gamble in the second quarter worth about $3,850,628,000. Bank of New York Mellon Corp acquired a new stake in shares of Procter & Gamble during the second quarter worth about $2,281,505,000. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Procter & Gamble by 2.6% during the first quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock worth $1,704,182,000 after purchasing an additional 300,280 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Analyst upgrade: Freedom Broker upgraded PG from “hold” to “buy,” providing a positive signal for the stock and reflecting greater confidence in the company’s outlook. Freedom Broker upgrades Procter & Gamble to buy from hold
• Positive Sentiment: Dividend appeal remains strong: Articles highlighted PG as a long-standing dividend leader, supporting its appeal to income-focused and defensive investors. The company’s record of dividend increases may help underpin demand for the shares, particularly when investors favor stable consumer-staples businesses. Dividend Kings article Trusted dividend stocks article
• Neutral Sentiment: Bond issuance adds balance-sheet context: PG’s euro- and dollar-denominated bond sale provides liquidity and funding flexibility, but it also draws attention to leverage, interest costs, and the company’s relatively elevated valuation. Procter & Gamble bond sale
• Neutral Sentiment: Growth story under review: Commentary on PG points to accelerating revenue growth, while also noting that higher operating costs could pressure margins and earnings. Investors are weighing improved sales momentum against cost inflation. Procter & Gamble revenue growth and costs What changed in Procter & Gamble’s story
• Negative Sentiment: Mixed rating signals and valuation risk: DZ Bank downgraded PG from “strong-buy” to “hold.” With shares trading at a premium valuation, a more cautious analyst stance could weigh on upside unless earnings growth accelerates. DZ Bank rating change
• Negative Sentiment: Advertising challenge produced only a limited win: Following PG’s challenge, the National Advertising Division supported Carpe’s $19.95 reference price but recommended changes or removal of other savings, free-shipping, comparative-performance, and “first” 100-hour protection claims. The outcome may modestly strengthen competitive advertising standards, but it does not represent a material financial catalyst for PG. National Advertising Division decision involving Carpe

Insider Activity

In other news, CFO Andre Schulten sold 3,914 shares of the stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the transaction, the chief financial officer owned 65,618 shares in the company, valued at $9,536,920.12. This trade represents a 5.63% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Shailesh Jejurikar sold 35,000 shares of the business’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the completion of the sale, the chief executive officer directly owned 55,391 shares of the company’s stock, valued at approximately $9,033,718.19. The trade was a 38.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 58,647 shares of company stock worth $9,268,508. Insiders own 0.23% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, September 21st. The Goldman Sachs Group reissued a “neutral” rating and set a $161.00 price target on shares of Procter & Gamble in a research report on Thursday, October 22nd. Barclays lifted their price objective on shares of Procter & Gamble from $152.00 to $165.00 and gave the company an “equal weight” rating in a research note on Monday. UBS Group set a $166.00 price objective on shares of Procter & Gamble in a research note on Friday, October 23rd. Finally, BNP Paribas Exane upped their price objective on shares of Procter & Gamble from $177.00 to $189.00 and gave the company an “outperform” rating in a report on Friday, October 23rd. Fifteen investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $170.57.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock opened at $161.42 on Friday. The firm has a market cap of $374.14 billion, a PE ratio of 24.31, a P/E/G ratio of 3.95 and a beta of 0.39. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. The business has a 50-day moving average price of $149.99 and a 200 day moving average price of $148.94.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The company had revenue of $23.28 billion for the quarter, compared to the consensus estimate of $22.80 billion. During the same quarter in the prior year, the business posted $1.99 earnings per share. Procter & Gamble’s revenue for the quarter was up 4.0% on a year-over-year basis. Sell-side analysts predict that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be paid a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s dividend payout ratio is presently 65.51%.

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.